The Osteoarthritis Clinical Studies Forum Series features OA thought leaders from across the globe discussing the future of how the disease can be treated to improve patient outcomes.

The Arthritis Foundation is mobilizing patients and their families to engage in studies comparing the effectiveness of treatments for juvenile arthritis and funding research for more options.

The Arthritis Foundation and the Childhood Arthritis and Rheumatology Research Alliance (CARRA) host a patient-focused drug development meeting.

A patient-focused drug development meeting gives doctors, researches and health providers a chance to hear from Osteoarthritis (OA) sufferers directly.

Train emerging leaders and accelerate FDA approval of new therapies.

Guidance documents have been developed by the Arthritis Foundation for patients who want to learn more about stem cell research.

Share your experience in a 10-minute assessment to be among those changing the future of arthritis.

The Arthritis Foundation partners with CARRA on The Registry, a tool to help answer important questions about these conditions.

See the Arthritis Foundation educational videos on the benefits available through participation in research.

Join patients, care providers, researchers and physicians in PARTNERS, and help improve the lives of children with rheumatic diseases and their families.

Learn more about the Arthritis Foundation’s key partners in the search for the cure to arthritis.

Who is on the front line of the fight against rheumatic diseases? Learn more information about our many collaborators in the struggle against arthritis.

See why we rely on PCORI and PCORnet to improve the quality of life and longevity of rheumatic disease patients.

These investigators are currently engaged in Arthritis Foundation-funded Rheumatic disease research.

See how the Arthritis Foundation is unique in having a community and national research agenda that is defined by patient voice, using data that comes directly from the patient community.

Mary K. Crow, MD, is the recipient of 2022 Lee C. Howley Sr. Prize for her significant contributions to arthritis research.

Read about past recipients of the Lee C. Howley Sr. Prize for Arthritis Scientific Research.

Learn about the recommended therapies for JA, including which types of medications should be used and when, how your child's doctor may approach treatment, and measures you and your child can take to help control arthritis and its symptoms.

Presenters discussed many aspects of osteoarthritis and development of drugs to treat it, including its epidemiology, challenges to assessing disease progression, potential biomarkers, difficulties of evaluating long-term benefits to the patient and challenges to achieving FDA approval. View and download the supporting presentations below.

Co-hosted by the FDA and the Arthritis Foundation on June 22, 2021

The first OA Clinical Studies forum highlights key international research.